Evexia Lifecare Limited, a prominent player in the pharmaceutical sector, has announced its unaudited financial results for the first quarter, showcasing robust growth across key financial metrics.

Standalone Performance Highlights

The company's standalone performance demonstrated significant improvement:

• Revenue from operations stood at Rs 2,065.80 lakhs, marking a slight increase from Rs 2,041.87 lakhs in the corresponding quarter of the previous year.
• Net profit saw a remarkable surge, rising by 122% to Rs 58.69 lakhs, compared to Rs 26.43 lakhs in the same period last year.
• Basic earnings per share (EPS) remained stable at Rs 0.003 for the quarter.

Consolidated Financial Results

On a consolidated basis, Evexia Lifecare Limited reported:

• Revenue from operations of Rs 2,209.32 lakhs, up from Rs 2,122.79 lakhs in the previous year's quarter.
• Net profit increased substantially to Rs 63.48 lakhs, compared to Rs 24.11 lakhs in the same quarter last year, representing a growth of 163%.
• Consolidated basic earnings per share stood at Rs 0.03 for the quarter.

Key Financial Metrics

Management Commentary

The Board of Directors reviewed and approved these unaudited financial results in their meeting held on August 14.

About Evexia Lifecare Limited

Evexia Lifecare Limited is engaged in the pharmaceutical sector. The company's registered office is located at Village Tundao, Taluka Savli, Vadodara, Gujarat.

Conclusion

Evexia Lifecare's quarterly results demonstrate the company's ability to drive growth and profitability in a competitive market environment. The significant increase in net profit, both on a standalone and consolidated basis, underscores the effectiveness of the company's strategic initiatives and operational excellence.

Evexia Lifecare Limited has announced a significant change in its promoter reclassification process, as five out of eight promoters have withdrawn their applications to be reclassified from the 'Promoter/Promoter Group' category to the 'Public' category.

Withdrawal Details

The company received letters dated August 01, 2025, from five promoters indicating their decision to withdraw their reclassification applications. The withdrawing promoters are:

These promoters had originally applied for reclassification in October 2024, along with three other promoters.

Continuing Applications

The reclassification applications of the following three promoters remain unaffected:

Implications

This development means that a significant portion of the promoter group that initially sought reclassification has now decided to maintain their current status. The reasons for the withdrawal have not been disclosed in the company's intimation to the stock exchange.

The reclassification process, if approved for the remaining three promoters, would still result in a minor reduction in the promoter group's shareholding. However, the impact will be less significant than initially anticipated when all eight promoters had applied for reclassification.

Evexia Lifecare Limited has submitted this information to the BSE Ltd. in compliance with Regulation 31A of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The company's management, led by Managing Director Jayeshbhai R. Thakkar, continues to oversee these corporate actions.

Investors and market participants will be watching closely to see how this change might affect the company's shareholding structure and any potential implications for corporate governance.